doxorubicin-mesoporphyrin conjugate (SLIL Biomedical)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug Namedoxorubicin-mesoporphyrin conjugate (SLIL Biomedical)
Drug Alias NameSL-11180
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVirus DNA polymerase inhibitorsDNA intercalatorsTopoisomerase II inhibitors
TargetsTopoisomerase IIDNAVirus DNA polymerase
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSLIL Biomedical Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSLIL Biomedical Corp
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A